Details for New Drug Application (NDA): 208371
✉ Email this page to a colleague
The generic ingredient in ABIRATERONE ACETATE is abiraterone acetate. There are twenty-five drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the abiraterone acetate profile page.
Summary for 208371
Tradename: | ABIRATERONE ACETATE |
Applicant: | Rising |
Ingredient: | abiraterone acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 208371
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 208371 | ANDA | Rising Pharma Holdings, Inc. | 64980-418 | 64980-418-12 | 120 TABLET in 1 BOTTLE (64980-418-12) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
Approval Date: | Feb 25, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription